Rebound-associated vertebral fractures after discontinuation of denosumab—from clinic and biomechanics

Summary Rebound-associated vertebral fractures may follow treatment discontinuation of highly potent reversible bone antiresorptives, resulting from the synergy of rapid bone resorption and accelerated microdamage accumulation in trabecular bone.